Launch week offerEnds in00h00m00s

annual Promonthly Pro

Giada Sebastiani

Canada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Canada

Articles (24)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (32)

Juan Gonzalez-Abraldes

Professor of Medicine

University of Alberta

CANADA

View details

Elisabetta Bugianesi

Full Professor of Gastroenterology

University of Turin

ITALY

View details

Mang Ma

Professor

CANADA

View details

Sahar Saeed

Assistant Professor

Queen's University

CANADA

View details

Caryn Morse

Professor

Wake Forest Baptist Medical Center

UNITED STATES

View details

Mohammad-Ali Jenabian

Professor

Université de Montréal

CANADA

View details

Dario Saltini

University of Modena and Reggio Emilia

ITALY

View details

Philip Newsome

Director of Roger Williams Institute of Liver Studies

University of Birmingham

UNITED KINGDOM

View details

Mattias Ekstedt

Linköping University

SWEDEN

View details

Avik Majumdar

University of Melbourne

AUSTRALIA

View details

Marco Constante

McMaster University

CANADA

View details

Vincent Wong

Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

Cecilia T. Costiniuk

McGill University

CANADA

View details

Mario Masarone

Professore Associato di Medicina Interna

University of Salerno

ITALY

View details

filippo schepis

University of Modena and Reggio Emilia

ITALY

View details

Hannes Hagström

Professor, Senior Consultant Hepatologist

Karolinska Institutet

SWEDEN

View details

Prasun K. Jalal

Baylor College of Medicine

UNITED STATES

View details

Jean-Pierre Routy

Professor

McGill University Health Centre

CANADA

View details

Rosa Martin-Mateos

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

SPAIN

View details

Manuela M Santos

Full Professor

Université de Montréal

CANADA

View details

Nicola Pugliese

Humanitas University

ITALY

View details

Federico Ravaioli

Research Doctorate (Ph.D.)

Universita degli Studi di Bologna Azienda Ospedaliera Sant'Orsola-Malpighi

ITALY

View details

Panu Luukkonen

University of Helsinki

FINLAND

View details

Emmanuel Tsochatzis

Professor of Hepatology and Consultant Hepatologist

University College London

UNITED KINGDOM

View details

Christopher D Byrne

University of Southampton

UNITED KINGDOM

View details

Anna Ludovica Fracanzani

Head of Complex Unit of Medicine and Metabolic Disease

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

ITALY

View details

Louis-Patrick Haraoui

Université de Sherbrooke

CANADA

View details

Frank Tacke

Charité - Universitätsmedizin Berlin

GERMANY

View details

Theodoros Androutsakos

National and Kapodistrian University of Athens

GREECE

View details

Bertrand Lebouché

McGill University

CANADA

View details

Javier Crespo

Director Científico Cohorte Cantabria

Instituto de Investigación Marqués de Valdecilla

SPAIN

View details

NIKOLAOS PAPADOPOULOS

Head

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giada Sebastiani

Research Interests

Make your next move.

Explore related searches

Articles (24)

Delphi survey to explore core curriculum for training the next generation of hepatologists

Diabetes and obesity reduce FIB-4 accuracy in MASLD referral pathways

The Economic Burden of Metabolic Dysfunction‐Associated Steatohepatitis (MASH) With Cirrhosis: A Systematic Review

Time‐Varying Impact of Steatosis and Alcohol on Mortality: A Marginal Structural Model of the Canadian Longitudinal Study on Aging

Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitis

Reply to “Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitis – Circular definition of CVRM comorbidities undermines the validity of core subgroup comparisons”

The Changing Etiological Landscape of Liver Cancer in the Era of Metabolic Disease

Reply to: “Hypertension and long-term adverse clinical outcomes in MASLD: Sensitivity analyses for unmeasured or uncontrolled confounding”

A cost-effectiveness analysis of a multidisciplinary model of care on hepatitis C care among people released from provincial prison in Quebec, Canada

Distinct Gut Microbiota Signatures Are Associated with Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease in People with HIV

Impact of first and further decompensation in patients with compensated ACLD due to MASLD

Call to action: integrating steatotic liver disease into public health strategies in Canada

Inclusive healthcare in light of the new MASLD guidelines: Should people living with HIV be screened for liver fibrosis?

Letter to the Editor: People living with HIV and NAFLD—A population left behind in the global effort for liver fibrosis screening?

Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial

Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial

Oxidative Stress in Liver Pathophysiology and Disease

Fibroscan–Aspartate Aminotransferase Score Predicts Liver-Related Outcomes, but Not Extrahepatic Events, in a Multicenter Cohort of People With Human Immunodeficiency Virus

Nutritional and Lifestyle Therapy for NAFLD in People with HIV

Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection

Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases

Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)

Collaborators (32)

Juan Gonzalez-Abraldes

Elisabetta Bugianesi

Mang Ma

Sahar Saeed

Caryn Morse

Mohammad-Ali Jenabian

Dario Saltini

Philip Newsome

Mattias Ekstedt

Avik Majumdar

Marco Constante

Vincent Wong

Cecilia T. Costiniuk

Mario Masarone

filippo schepis

Hannes Hagström

Prasun K. Jalal

Jean-Pierre Routy

Rosa Martin-Mateos

Manuela M Santos

Nicola Pugliese

Federico Ravaioli

Panu Luukkonen

Emmanuel Tsochatzis

Christopher D Byrne

Anna Ludovica Fracanzani

Louis-Patrick Haraoui

Frank Tacke

Theodoros Androutsakos

Bertrand Lebouché

Javier Crespo

NIKOLAOS PAPADOPOULOS

Make your next move.